Concepedia

Jun Xu

JX

Statistics

Publications

31

Citations

6.7K

H-Index

22

Active since

2009

Affiliations

University of Pennsylvania(Current)

Parker Institute for Cancer Immunotherapy

Novartis (United States)

Children's Hospital of Philadelphia

University of Alabama at Birmingham

Jun Xu is an author at University of Pennsylvania specializing in immunology, life sciences, and oncology.

ORCID

Publications per year

2009–2022

31

Publications

31

Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia

Joseph A. Fraietta, Simon F. Lacey, Elena J. Orlando et al. · Nature Medicine · 2018 · 1.8K citations · Full text

, , +16

CRISPR-engineered T cells in patients with refractory cancer

Edward A. Stadtmauer, Joseph A. Fraietta, Megan M. Davis et al. · Science · 2020 · 1.4K citations · Full text

, , +17

Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells

Joseph A. Fraietta, Christopher L. Nobles, Morgan A. Sammons et al. · Nature · 2018 · 861 citations · Full text

, , +14

Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell

Marco Ruella, Jun Xu, David M. Barrett et al. · Nature Medicine · 2018 · 645 citations · Full text

, , +12

PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial

Vivek Narayan, Julie S. Barber-Rotenberg, In-Young Jung et al. · Nature Medicine · 2022 · 500 citations · Full text

, , +14

1–5 of 31